Prostate cancer is a vast and complicated field. To make it more manageable, PCRI breaks it down into five separate Shades of Blue. Men with recurrent disease after surgery or radiation are in the INDIGO shade. The outlook for men with INDIGO is optimistic. Some men can still be cured. For those who can’t, the vast majority will be able to keep their disease in check with treatment.
A rising PSA confirmed on sequential
measurements is the most common sign of a relapse.
Less common signs of
relapse are:
a.
A
positive biopsy from the prostate fossa. The “fossa” is where the prostate
gland used to be prior to surgery (also, a nodule may or may not be felt on
digital rectal examination)
b.
Persistent
prostate cancer detected in the gland after radiation by needle biopsy, or by
scans or by digital rectal examination
c.
Prostate
cancer that has been detected in the pelvic lymph nodes by a scan.
After radiation, the prostate gland remains in place. Therefore, in men who have been recently treated with radiation combined with testosterone inactivating pharmaceuticals (TIP), discontinuing TIP will lead to testosterone recovery which causes PSA levels to rise. Also, radiation-induced inflammatory reactions can occur in residual prostate gland cause a PSA rise. This rather common phenomenon is called the “PSA Bump.” It’s essential to be aware of the noncancerous causes of PSA elevation so that well-intentioned but unnecessary treatment can be avoided.
INDIGO men will require imaging studies to
determine the extent of the disease.
1.
Color
Doppler or MRI is used to look for residual cancer located in the surgical
fossa or in the prostate gland in men previously treated with radiation.
2.
Pelvic
MRI or CT scans are used to look for spread to pelvic lymph nodes. (Carbon 11 acetate
PET scan is more accurate than CT or MRI but is still considered to be under
investigation)
3.
CT or MRI of the abdomen and bone scans are
used to detect the presence of more distant spread to lymph nodes outside the
pelvis or to the bones. Scan-detected disease outside the pelvis or in the
bones changes the shade to ROYAL.
Treatment
for INDIGO
Treatment options include observation,
radiation, TIP, cryotherapy, or combinations of TIP with radiation or
cryotherapy. Treatment selection is guided by four factors—the cancer location,
the original Shade, the PSA doubling time and a patient’s age. By incorporating
all four factors into the treatment selection process, the risk over-treating, i.e., incurring
unnecessary side effects from treatment, is reduced. Awareness of all four of the factors also
helps to avoid another common mistake—under-treating—which
reduces the likelihood of achieving durable remission.
An isolated “local” relapse is one that
appears to be localized inside the prostate after radiation. Local relapse may
be curable with cryosurgery alone. An
isolated “local” relapse in the prostate fossa after surgery may be curable
with radiation alone.
When no local disease can be detected and
when all the scans are clear—termed a “pure” PSA relapse—treatment selection
will be influenced primarily by the rate of PSA rise. For example, if the PSA
is doubling in less than six months, aggressive combination treatment with TIP
plus radiation or TIP plus cryosurgery may be best. If the PSA doubling rates is between six and
twelve months, a less aggressive treatment approach with radiation alone,
cryosurgery alone or intermittent TIP alone, is reasonable. When the doubling time is greater than 12
months, observation without immediate treatment may be considered.
A patient’s age and the original shade at the
time of diagnosis also need to be factored into the treatment decision-making
process. Men who are more elderly can “step down” the intensity of their
treatment plan by temporizing with mild forms of TIP, such as low-dose Casodex.
Younger men, who prior to relapse, were in the High-Risk (AZURE) category may want to consider prophylactic pelvic
lymph node radiation, a more intensive type of TIP with Zytiga or Xtandi or
even chemotherapy with Taxotere.
Side
Effects of Treatment—INDIGO
The residual prostate gland after radiation
is anatomically close to the rectum, urinary bladder, and the nerves that
control erections. Therefore treatment with salvage radiation or cryotherapy
increases the risk of additional long-term sexual, urinary or rectal
dysfunction beyond what has already caused by the original surgery or
radiation.
Men who are already struggling with
incontinence problems from previous surgery may experience further decline in
their urinary control when they undergo radiation directed at the fossa. Men
who have cryosurgery for a relapse after radiation almost always become
impotent. Incontinence can also occur. Surgery to remove a previously radiated
prostate causes very high rates of impotence and incontinence.
Radiation to the pelvic lymph nodes can cause
damage to the surrounding intestines with symptoms of cramping, diarrhea or
loss of rectal control. Since the advent of intensity modulated radiation
(IMRT), however, bowel damage from pelvic radiation is a much less common event.
TIP is a common component of the treatment
plan for men in the INDIGO category. The severity of side effects from TIP
increases when it is continued for a longer duration. As a result, intermittent TIP is very popular. The
intermittent TIP protocol is to continue treatment for six to twelve month
after which TIP is stopped and a treatment “holiday” is ensues—assuming the PSA
drops below the 0.1/ng threshold. The next cycle of TIP is resumed when the PSA
rises back to the original PSA baseline, or up to five, whichever is lower.
The most troublesome side effects from TIP
are weight gain and fatigue. Maintaining a careful diet and doing regular
exercise is very helpful in offsetting these problems. Low libido, however,
only responds to a treatment holiday. Daily Cialis is necessary to reduce the
risk of permanent erectile atrophy.
Other side effects of TIP typically respond
well to the following medications:
Low-dose estrogen controls hot flashes. Osteoporosis can be prevented by
Prolia, Boniva or Actonel. Mood swings stabilize with antidepressants. Breast
growth is prevented with nipple radiation or Femara. Erectile dysfunction can be counteracted with
Viagra.
Finding the right type of treatment for men
in INDIGO is achieved when the benefit of treatment is weighed carefully
against the potential for treatment-related side effects. Fortunately, a wide
variety of effective treatment is available for men with INDIGO and the
majority will have their disease controlled on a long term basis.
So much for getting “the Blues” when you have
prostate cancer!
No comments:
Post a Comment